News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

IVAX Corporation (IVX) To Distribute Mayne Pharma Injectable Oncology Products In Central And Eastern Europe


10/19/2005 5:09:24 PM

MIAMI--(BUSINESS WIRE)--July 1, 2005--IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that IVAX has signed an agreement with Mayne Pharma under which IVAX will exclusively distribute a number of Mayne's generic injectable oncology products for certain markets in Central and Eastern Europe. Mayne Pharma will manufacture the products and receive payments from IVAX based on product sales. IVAX Corporation, headquartered in Miami, Florida, discovers, develops, manufactures, and markets branded and brand equivalent (generic) pharmaceuticals and veterinary products in the U.S. and internationally.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES